Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
737
Total Claims
$959K
Drug Cost
89
Beneficiaries
$11K
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 5,101 Rheumatology providers
+78%
Cost per patient vs peers
$11K vs $6,039 avg
+186%
Brand preference vs peers
21.7% vs 7.6% avg
Brand vs Generic
Brand: 160 claims · $929K
Generic: 577 claims · $30K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Adalimumab | 35 | $293K |
| Upadacitinib | 20 | $128K |
| Adalimumab | 15 | $112K |
| Abatacept | 11 | $61K |
| Mycophenolate Mofetil | 19 | $13K |
| Methotrexate Sodium | 126 | $4,711 |
| Hydroxychloroquine Sulfate | 87 | $3,889 |
| Lidocaine | 12 | $1,327 |
| Diclofenac Sodium | 33 | $1,182 |
| Colchicine | 15 | $1,083 |
| Allopurinol | 57 | $845 |
| Prednisone | 56 | $528 |
| Duloxetine Hcl | 14 | $489 |
| Sulfasalazine | 23 | $420 |
| Alendronate Sodium | 18 | $156 |
Prescribing Profile
16
Unique Drugs
3.0
Anomaly Score
Patient Profile
68
Avg Age
70%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About